Clot Management Devices Market to Grow at 5.11% through 2030F
Increasing cardiovascular diseases
is expected to drive Global Clot Management Devices Market during the forecast
period, 2026-2030F.
According to TechSci Research
report, “Clot Management Devices Market - Global Industry Size, Share,
Trends, Opportunity, and Forecast, 2020-2030”, Global Clot Management Devices Market was valued at USD 1.85 billion in 2024 and is expected to reach USD 2.47 billion by 2030 with a CAGR of 5.11% during the forecast period. This can be ascribed to the increasing coronary
heart disease, periphery arterial diseases, stroke and venous thromboembolism
is further expected to increase the demand for clot management devices.
Similarly, increasing geriatric population, increasing demand for effective
thrombectomy or embolectomy devices and increasing awareness regarding newer
approaches for clot management device, and growing awareness of using clot
management device amongst the patient and healthcare professionals across the
world is expected to drive global clot management devices market during the
forecast period.
However, reimbursement procedures are not well defined in many developing
countries which may restrain the growth of the global clot management devices
market during the forecast period. Additionally, high cost of clot management
devices and availability of alternative treatments are expected to hamper the
overall market growth.
Browse over XX market data Figures
spread through XX Pages and an in-depth
TOC on "Clot Management Devices Market"
The global clot management
devices market is segmented on the basis of
product type, end user, and region.
Based on product type, neurovascular
embolectomy devices are the fastest growing segment. This growth is driven
primarily by the increasing prevalence of ischemic strokes, which make up the
majority of stroke cases globally. Neurovascular embolectomy devices are
specifically designed to remove clots from cerebral arteries, restoring blood
flow and minimizing brain damage. Continuous advancements in technology have
improved their effectiveness and safety, making them the preferred treatment
option for acute ischemic stroke patients. Additionally, the growing preference
for minimally invasive procedures contributes to their rising adoption, as
these devices offer shorter recovery times and fewer complications compared to
traditional surgical methods. The combination of increasing stroke incidence,
technological innovation, and patient demand for less invasive treatments
supports the rapid expansion of neurovascular embolectomy devices in the
market.
Based on region, The Asia-Pacific
region is experiencing the fastest growth in the global clot management devices
market due to several key factors. Firstly, the region is witnessing a
significant demographic shift, with a rapidly increasing geriatric population.
This demographic is more susceptible to thromboembolic disorders such as deep
vein thrombosis (DVT) and pulmonary embolism (PE), thereby driving the demand
for effective clot management solutions. Secondly, there is a growing
prevalence of cardiovascular diseases across countries like China, India, and
Japan. This rise is attributed to lifestyle changes, urbanization, and an
increase in risk factors such as hypertension and diabetes, further contributing
to the need for advanced clot management devices. Thirdly, substantial
investments in healthcare infrastructure and medical technologies are enhancing
the accessibility and quality of healthcare services. These improvements
facilitate the adoption of innovative clot management solutions, particularly
in emerging markets within the region. The heightened awareness about
preventive healthcare and thromboembolic disorders is leading to earlier
diagnosis and treatment, thereby increasing the utilization of clot management
devices.
Major companies operating in global
clot management devices market are:
·
Medtronic Plc.
·
Concentric Medical, Inc.
·
Boston Scientific Corporation
·
Edward LifeSciences Corporation
·
AngioDynamics, Inc.
·
LeMaitre Vascular, Inc.
·
Teleflex Incorporated
·
Johnson & Johnson
·
Strub Medical GmbH & Co. KG
·
Cook Group Incorporated
Download Free Sample Report
Customers can also request for 10%
free customization on this report.
“The aging population is a major driver of the global clot management devices market. As individuals age, their risk of developing thromboembolic disorders such as deep vein thrombosis, pulmonary embolism, and ischemic stroke increases significantly. Age-related changes in the vascular system, reduced mobility, and the presence of multiple chronic conditions contribute to a higher likelihood of blood clot formation. Elderly patients often undergo surgeries or long hospital stays, which can lead to prolonged immobility—a known risk factor for venous thromboembolism. This demographic shift is expanding the patient base requiring effective and timely clot management solutions. With global life expectancy on the rise, healthcare systems are seeing a growing number of elderly patients who require advanced treatment for cardiovascular and thrombotic conditions. Clot management devices offer a less invasive and efficient approach to restoring blood flow, which is especially important in older patients who may not be ideal candidates for more invasive surgical procedures. The ability to quickly remove clots with minimal recovery time is appealing for this age group, as it reduces hospital stays and the risk of further complications. Medical professionals are increasingly adopting clot retrieval and thrombolysis devices to address the unique needs of aging patients. Device manufacturers are also focusing on developing technologies that are tailored to the physiological characteristics of older adults. As the elderly population continues to grow, the demand for safe, effective, and rapid clot management solutions is expected to increase, making it a critical segment of the market’s ongoing expansion”, said Mr. Karan Chechi,
Research Director of TechSci Research, a research-based global management
consulting firm.
“Clot Management Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented by Product Type (Neurovascular Embolectomy Devices, Embolectomy Balloon Catheters, Percutaneous Thrombectomy Devices, Catheter Directed Thrombolysis Devices, Others), By End User (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region and Competition, 2020-2030F”, has evaluated the future
growth potential of global clot management devices market and provides
statistics & information on market size, structure, and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in global clot management devices market.
Contact
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New
York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com